Thus, it would be important to further investigate whether celecoxib ameliorates hepatic insulin resistance by regulating TNF‐α signalling in a NAFLD mouse model induced by Akt‐driven lipogenesis and characterized by insulin resistance. Here, AKT1 is linked to metabolic dysfunction-associated steatotic liver disease.